Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Improving Memory in Alzheimer's Disease With Noninvasive Brain Stimulation

NCT: NCT06094192 · RECRUITING

NCT IDNCT06094192
StatusRECRUITING
Start Date2023-12-20
Completion2028-05-31
SponsorBoston University Charles River Campus (OTHER)
First posted
Last updated

Brief Summary

The investigators will evaluate the theory that Alzheimer's disease-related memory impairment derives from the inefficient orchestration of rhythmic activity at the level of large-scale cortical networks. The results as expected to elucidate AD-related pathophysiology and set groundwork for the development of drug-free interventions for improving memory in AD and related dementias.

Frequently Asked Questions

What is Improving Memory in Alzheimer's Disease With Noninvasive Brain Stimulation?

Improving Memory in Alzheimer's Disease With Noninvasive Brain Stimulation is a clinical trial registered under NCT06094192. Current status: RECRUITING.

What is the status of NCT06094192?

The current status of NCT06094192 (Improving Memory in Alzheimer's Disease With Noninvasive Brain Stimulation) is: RECRUITING.

When did Improving Memory in Alzheimer's Disease With Noninvasive Brain Stimulation start?

Improving Memory in Alzheimer's Disease With Noninvasive Brain Stimulation started on 2023-12-20.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.